(Q27000801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Manuela Simoni

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Jerzy-Roch Nofer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

1 reference

1 August 2014

1 reference

published in

Cardiovascular Research

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

103

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

395-404

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Effects of dalcetrapib in patients with a recent acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Regulation of high-density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate signaling and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine kinase 1 in viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

S1P is associated with protection in human and experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Autocrine and paracrine roles of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

The outs and the ins of sphingosine-1-phosphate in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingolipid signaling in metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Finding a way out: lymphocyte egress from lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Erythrocytes store and release sphingosine 1-phosphate in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Vascular endothelium as a contributor of plasma sphingosine 1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Isolation and characterization of human apolipoprotein M-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Apolipoprotein M: bridging HDL and endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Plasma sphingosine-1-phosphate is elevated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Functions of scavenger receptor class B, type I in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Identification of a potent serum factor that causes desensitization of the receptor for C-Type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Regulation of macrophage function by sphingosine-1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU136

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json

release_ipr22othhrfnjiwcidyf23ouhi

6 June 2020

Fatcat ID

0 references

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24891400%20AND%20SRC:MED&resulttype=core&format=json